Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Baylor College of Medicine
Washington University School of Medicine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wake Forest University Health Sciences
Stanford University
Stanford University
University of Nebraska
Baylor College of Medicine
Tessa Therapeutics
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
National Cancer Centre, Singapore
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Swiss Cancer Institute
Ohio State University Comprehensive Cancer Center
Virginia Commonwealth University
National Cancer Institute (NCI)
Morphotek
Case Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
SWOG Cancer Research Network
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)